BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J Hepatol 2004;41:1041-4. [PMID: 15582140 DOI: 10.1016/j.jhep.2004.10.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Kazemi-shirazi L, Zacharasiewicz A, Smaczny C, Ellemunter H. Cystische Fibrose. Wien Klin Wochenschr Educ 2013;8:15-42. [DOI: 10.1007/s11812-013-0058-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Lavelle LP, Mcevoy SH, Ni Mhurchu E, Gibney RG, Mcmahon CJ, Heffernan EJ, Malone DE. Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients. RadioGraphics 2015;35:680-95. [DOI: 10.1148/rg.2015140110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
3 Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 2006;121:350-7. [PMID: 17052957 DOI: 10.1016/j.clim.2006.08.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
4 Karlas T, Neuschulz M, Oltmanns A, Güttler A, Petroff D, Wirtz H, Mainz JG, Mössner J, Berg T, Tröltzsch M, Keim V, Wiegand J. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. PLoS One 2012;7:e42139. [PMID: 22848732 DOI: 10.1371/journal.pone.0042139] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
5 Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10 Suppl 2:S29-S36. [PMID: 21658639 DOI: 10.1016/s1569-1993(11)60006-4] [Cited by in Crossref: 233] [Cited by in F6Publishing: 69] [Article Influence: 21.2] [Reference Citation Analysis]
6 Breuer O, Shteyer E, Wilschanski M, Perles Z, Cohen-cymberknoh M, Kerem E, Shoseyov D. Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease. Chest 2016;149:e35-8. [DOI: 10.1016/j.chest.2015.10.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology 2015;62:1551-62. [PMID: 26199136 DOI: 10.1002/hep.28000] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
8 Akata D, Akhan O. Liver manifestations of cystic fibrosis. Eur J Radiol 2007;61:11-7. [PMID: 17174503 DOI: 10.1016/j.ejrad.2006.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
9 Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43 Suppl 1:S49-55. [PMID: 16819402 DOI: 10.1097/01.mpg.0000226390.02355.52] [Cited by in Crossref: 67] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
10 Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, Leonardi S. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13:e11215. [PMID: 24171010 DOI: 10.5812/hepatmon.11215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
11 Florentino RM, Li Q, Coard MC, Haep N, Motomura T, Diaz-Aragon R, Faccioli LAP, Amirneni S, Kocas-Kilicarslan ZN, Ostrowska A, Squires JE, Feranchak AP, Soto-Gutierrez A. Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells. Hepatol Commun 2022. [PMID: 35289126 DOI: 10.1002/hep4.1920] [Reference Citation Analysis]
12 Monti L, Manco M, Lo Zupone C, Latini A, D'Andrea ML, Alghisi F, Lucidi V, Tomà P, Bonomo L. Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children. Radiol Med 2012;117:1408-18. [PMID: 22986694 DOI: 10.1007/s11547-012-0874-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
13 Fiorotto R, Villani A, Kourtidis A, Scirpo R, Amenduni M, Geibel PJ, Cadamuro M, Spirli C, Anastasiadis PZ, Strazzabosco M. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Hepatology. 2016;64:2118-2134. [PMID: 27629435 DOI: 10.1002/hep.28817] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
14 He D, Wilborn TW, Falany JL, Li L, Falany CN. Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes. Biochim Biophys Acta 2008;1783:2391-7. [PMID: 18817817 DOI: 10.1016/j.bbamcr.2008.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529-536. [PMID: 17901760 DOI: 10.1097/mcp.0b013e3282f10a16] [Cited by in Crossref: 115] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
16 Siano M, De Gregorio F, Boggia B, Sepe A, Ferri P, Buonpensiero P, Di Pasqua A, Raia V. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Dig Liver Dis 2010;42:428-31. [PMID: 20034860 DOI: 10.1016/j.dld.2009.07.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
17 Gobato AO, Vasques ACJ, Ribeiro AF, Yamada RM, Hessel G. PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS. Rev paul pediatr 2019;37:435-41. [DOI: 10.1590/1984-0462/;2019;37;4;00007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Manco M, Zupone CL, Alghisi F, D'andrea ML, Lucidi V, Monti L. Pilot study on the use of acoustic radiation force impulse imaging in the staging of cystic fibrosis associated liver disease. Journal of Cystic Fibrosis 2012;11:427-32. [DOI: 10.1016/j.jcf.2012.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
19 Cottart CH, Bonvin E, Rey C, Wendum D, Bernaudin JF, Dumont S, Lasnier E, Debray D, Clément A, Housset C, Bonora M. Impact of nutrition on phenotype in CFTR-deficient mice. Pediatr Res 2007;62:528-32. [PMID: 17805210 DOI: 10.1203/PDR.0b013e318155a61d] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
20 Sommerburg O, Schenk JP. [Abdominal manifestations in cystic fibrosis : Clinical review]. Radiologe 2020;60:781-90. [PMID: 32776239 DOI: 10.1007/s00117-020-00729-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]